Creatine oral supplementation using creatine hydrochloride salt

US10342771B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10342771-B2
Application numberUS-201815968858-A
CountryUS
Kind codeB2
Filing dateMay 2, 2018
Priority dateMay 15, 2003
Publication dateJul 9, 2019
Grant dateJul 9, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is directed to an oral supplement including creatine hydrochloride, which has an aqueous solubility that is at least 15 times greater than creatine monohydrate, where the oral supplement drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.

First claim

Opening claim text (preview).

What is claimed is: 1. A nutritional supplement comprising: a granular precipitate comprising creatine hydrochloride, wherein the granular precipitate has an aqueous solubility of at least about 150 mg/mL in water at 25° C. after a time period of about 1.5 hours. 2. The nutritional supplement of claim 1 , wherein the granular precipitate comprises at least 95 percent creatine hydrochloride by weight of the granular precipitate. 3. The nutritional supplement of claim 1 , wherein the granular precipitate has an aqueous solubility of at least 600 mg/mL in water at 25° C. after a time period of about 1.5hours. 4. The nutritional supplement of claim 1 , comprised in a powder. 5. The nutritional supplement of claim 1 , comprised in an additive or feed supplement for livestock. 6. The nutritional supplement of claim 1 , comprised in an oral dosage form. 7. A nutritional supplement comprising: a granular precipitate comprising creatine hydrochloride, wherein the granular precipitate has an aqueous solubility in water of at least an order of magnitude greater than creatine monohydrate. 8. The nutritional supplement of claim 7 , further comprising at least one additive comprising one or more proteins, amino acid supplements, carbohydrates, D-Ribose, fats, fiber, sweeteners, flavoring agents, or combinations thereof. 9. The nutritional supplement of claim 7 , wherein the granular precipitate comprises at least about 95 percent creatine hydrochloride by weight of the granular precipitate. 10. The nutritional supplement of claim 7 , comprised in an oral dosage form. 11. The nutritional supplement of claim 10 , wherein the oral dosage form is a powder. 12. The nutritional supplement of claim 10 , wherein the oral dosage form is a pill, capsule, tablet, or liquid. 13. The nutritional supplement of claim 8 , wherein the at least one additive is a sweetener selected from the group consisting of sucralose, aspartame, saccharin, acesulfame potassium, neohesperidin dihydrochalcone, glycyrrhizin, thaumatin, alitame, stevioside, and combinations thereof. 14. The nutritional supplement of claim 13 , further comprising a flavoring agent selected from the group consisting of cocoa, yogurt, peanut butter, mint, cheesecake, hazelnut paste, almonds, granola, coconut, strawberry, banana, cherry, plum, raspberry, lemon, orange, lime, pineapple, blueberry and other fruit flavors, coffee, cremes, jellies, and combinations thereof. 15. A nutritional supplement comprising: a granular precipitate comprising creatine hydrochloride, wherein the granular precipitate has an aqueous solubility of at least about 150 mg/mL in water at 25° C. after a time period of about 1.5 hours; and at least one additive comprising one or more proteins, amino acid supplements, carbohydrates, D-Ribose, fats, fiber, sweeteners, flavoring agents, or combinations thereof. 16. The nutritional supplement of claim 15 , wherein the granular precipitate comprises at least 95 percent creatine hydrochloride by weight of the granular precipitate. 17. The nutritional supplement of claim 15 , comprised in a pill, tablet, capsule, or liquid. 18. The nutritional supplement of claim 15 , comprised in a powder. 19. The nutritional supplement of claim 15 , wherein the granular precipitate has an aqueous solubility of at least 600 mg/mL in water at 25° C. after a time period of about 1.5 hours. 20. A nutritional supplement comprising: a first granular precipitate comprising creatine hydrochloride, wherein the granular precipitate has an aqueous solubility of at least about 150 mg/mL in water at 25° C. after a time period of about 1.5 hours; and a creatine selected from the group consisting of creatine ester, creatine pyruvate, creatine phosphate, creatine alpha-ketoglutarate, creatine citrate, and combinations thereof. 21. The nutritional supplement of claim 20 , further comprising HMB, L-glutamine, ribose, or a combination thereof. 22. The nutritional supplement of claim 20 , further comprising a flavoring agent.

Assignees

Inventors

Classifications

  • Anabolic agents (androgens A61P5/26) · CPC title

  • Organic substances · CPC title

  • for ruminants · CPC title

  • Amino acids; Derivatives thereof · CPC title

  • Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion {or mevinphos} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10342771B2 cover?
The present invention is directed to an oral supplement including creatine hydrochloride, which has an aqueous solubility that is at least 15 times greater than creatine monohydrate, where the oral supplement drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
Who is the assignee on this patent?
Vireo Systems Inc, Univ Nebraska
What technology area does this patent fall under?
Primary CPC classification A61K31/198. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).